pars plana vitrectomy (PPV)

平坦部玻璃体切除术 ( PPV )
  • 文章类型: Journal Article
    黄斑水肿(ME)仍然是葡萄膜炎视力恶化的主要原因。视力(VA)通常可以使用皮质类固醇储库系统来维持。这项研究使用真实世界数据评估了氟轻松(FAc)玻璃体内植入物(ILUNEN®)治疗非感染性葡萄膜炎的疗效。这项回顾性分析包括135只眼睛,细分为响应者和非响应者。中央视网膜厚度(CRT),VA,和眼压(IOP)随时间的推移进行随访。在整个随访期间,观察到所有眼睛的CRT显着降低和VA增加(p<0.01)。IOP增加(p=0.028)需要到第6个月治疗43%的眼睛。无反应者年龄较大(p=0.004),并接受了更多的地塞米松(DEX)植入物治疗(p=0.04);89.3%的外界膜(ELM)和内/外节(IS/OS)区存在缺陷(p<0.001)。免疫调节治疗对治疗反应无影响。与非PPV患者相比,平坦部玻璃体切除术(PPV)患者的平均CRT降低为47.55µm,并且到第24个月时效果降低(p=0.046)。我们得出的结论是,FAc植入物可实现对CRT的长期控制并改善VA。IOP的增加是可控的。具有先前PPV的眼睛显示较温和的结果。数据显示老年人之间存在相关性,损坏的ELM和IS/OS区域,频繁的DEX插入,和较差的结果衡量标准。
    Macular edema (ME) remains a primary cause of visual deterioration in uveitis. Visual acuity (VA) can often be maintained using corticosteroid depot systems. This study evaluated the efficacy of a fluocinolone acetonide (FAc) intravitreal implant (ILUVIEN®) in treating non-infectious uveitis using real-world data. This retrospective analysis included 135 eyes subdivided into responders and non-responders. Central retinal thickness (CRT), VA, and intraocular pressure (IOP) were followed over time. A significant decrease in CRT and an increase in VA were observed in all eyes throughout the follow-up period (p < 0.01). An IOP increase (p = 0.028) necessitated treatment in 43% of eyes by Month 6. Non-responders were older (p = 0.004) and had been treated with more dexamethasone (DEX) implants (p = 0.04); 89.3% had a defect in the external limiting membrane (ELM) and inner/outer segment (IS/OS) zone (p < 0.001). Immunomodulatory therapy had no impact on treatment response. Pars plana vitrectomy (PPV) patients had a mean CRT reduction of 47.55 µm and a reduced effect by Month 24 (p = 0.046) versus non-PPV patients. We conclude that the FAc implant achieves long-term control of CRT and improves VA. Increases in IOP were manageable. Eyes with a previous PPV showed milder results. Data showed a correlation between older age, a damaged ELM and IS/OS zone, frequent DEX inserts, and poorer outcome measures.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    用于眼内使用的理想染料应有效地将目标组织染色,同时易于施加和去除。此外,它不应该有任何副作用导致与视网膜组织长期接触。最近,人们对某些活体染料在外科手术过程中的安全性提出了担忧,因为它们可能会穿过内界膜并沉积在视网膜上。在这项研究中,我们的目的是调查是否市售的至关重要的染料,VIEW-ILM®和TWIN®(AL.CHI.MI.A.S.r.l.,PonteSanNicoló,帕多瓦,意大利),在玻璃体视网膜手术期间有可能穿过内界膜并沉积在视网膜上。此外,我们在体外和体内评估了它们的安全性。
    在离体的猪眼睛上进行了类似人的平坦部玻璃体切除术,使用VIEW-ILM®或TWIN®对内部限制膜进行染色,有或没有随后的内部限制膜剥离。然后从有或没有内界膜的视网膜穿孔中提取两种染料,并使用高效液相色谱法进行定量。根据ISO标准,通过体外细胞毒性试验和体内皮肤致敏和刺激试验评价安全性。
    高效液相色谱分析表明,VIEW-ILM®和TWIN®有效地染色内界膜而不穿过膜。去除内界膜后,在视网膜层中没有发现残留的染料。此外,体外和体内安全性测试均证实不存在细胞毒性,皮肤致敏,和刺激。
    本研究结果支持VIEW-ILM®和TWIN®用于内界膜染色的安全性和有效性。本研究中描述的实验方案可用于全面了解活体染料的特性。
    An ideal dye for intraocular use should effectively stain the target tissue while being easy to apply and remove. Additionally, it should not have any adverse effects resulting from prolonged contact with the retinal tissue. Recently, concerns have been raised about the safety of some vital dyes during surgical procedures as they may cross the internal limiting membrane and deposit on the retina. In this study, we aimed to investigate whether commercially available vital dyes, VIEW-ILM® and TWIN® (AL.CHI.MI.A. S.r.l., Ponte San Nicolò, Padova, Italy), have the potential to cross the internal limiting membrane during vitreoretinal surgery and deposit on the retina. Furthermore, we evaluated their safety in vitro and in vivo.
    A human-like pars plana vitrectomy was performed on porcine eyes ex vivo, with VIEW-ILM® or TWIN® used to stain the internal limiting membrane either with or without subsequent internal limiting membrane peeling. The two dyes were then extracted from retinal punches with or without internal limiting membrane, and quantified using high performance liquid chromatography. Safety was evaluated through in vitro cytotoxicity tests and in vivo skin sensitization and irritation tests according to ISO standards.
    High performance liquid chromatography analyses demonstrated that VIEW-ILM® and TWIN® effectively stained the internal limiting membrane without crossing the membrane. No residual dyes were found in the retinal layers after internal limiting membrane removal. Furthermore, both in vitro and in vivo safety tests confirmed the absence of cytotoxicity, skin sensitization, and irritation.
    The results of this study support the safety and efficacy of VIEW-ILM® and TWIN® for internal limiting membrane staining. The experimental protocol described in this study could be utilized to gain a comprehensive understanding of the characteristics of vital dyes.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    本研究旨在描述一种用于FILSSF晶状体的新型改良手术技术(罗马,意大利:索莱科)植入。对6例半脱位或脱位人工晶状体(IOL)患者的6只眼进行FILSSF晶状体植入术的回顾性研究。所有患者均进行标准平坦部玻璃体切除术(PPV)。从2.4个角膜切口中取出半脱位或脱位的IOL。从同一个切口,插入折叠的FILSSF透镜。然后通过在手术开始时产生的两个4mm口袋内的23G巩膜切口将晶状体塞扩张。在两种情况下,必须将一个口袋转换为三角形的巩膜瓣。所有巩膜袋用7.0Vicryl缝合线缝合,结膜用7.0Vicryl缝合。在六个月的随访期内,镜头居中,不倾斜。屈光结果在预期之内。所有患者的视力均得到改善。在所有情况下,均未发现触觉暴露和其他并发症。FILSSF镜头是治疗无晶状体的一个很好的选择。这种改良的植入技术是安全的,快,而且很容易.它也是多才多艺的,结合了上述两种技术的优点,因为它给出了襟翼转换的选项,如果需要。大型研究和前瞻性比较研究可以突出最佳和更合适的技术。
    This study aimed to describe a novel modified surgical technique for FIL SSF lens (Rome, Italy: Soleko) implantation. A retrospective study of FIL SSF lens implantation on six eyes of six patients with subluxated or dislocated intraocular lens (IOL). Standard pars plana vitrectomy (PPV) was performed in all patients. The subluxated or dislocated IOL was removed from a 2.4 corneal incision. From the same incision, the folded FIL SSF lens was inserted. Then lens plugs were extremized through a 23G scleral incision inside two 4 mm pockets that were created at the beginning of the operation. In two cases one pocket had to be converted into a triagonal-shaped scleral flap. All scleral pockets were sutured with 7.0 Vicryl suture and the conjunctiva with 7.0 Vicryl. In the follow-up period of six months, the lens is centered and not tilted. The refractive outcome is within the expectations. Visual acuity is improved in all patients. No haptic exposure and no other complications were noted in all cases. FIL SSF lens is a good option for treating aphakia. This modified implantation technique is safe, fast, and easy. It is also versatile, combining the advantages of both previously described techniques, as it gives the option of flap conversion if needed. Larger studies and prospective comparative studies can highlight the best and more appropriate technique.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:探讨不同手术技术行瓣膜性和非瓣膜性玻璃体切割术(PPV)后巩膜切开术部位结膜色素沉着的发生率和危险因素。
    方法:这是一项前瞻性观察性研究,包括70例因孔源性视网膜脱离而接受PPV的患者的70只眼,随访1、3、6、12和24个月。使用25G无瓣套管(A组)对28只眼进行手术,22只眼睛使用25G无瓣套管(B组),和20只眼睛使用25G带阀套管(C组)。评估的临床参数包括手术技术,病人的年龄,视网膜撕裂的数量,填塞剂,残余视网膜下液(SRF)的存在,以及术后姿势的持续时间。
    结果:在PPV后6个月内,A组有显著的结膜色素沉着。六氟化硫(SF6)气体填塞与3个月随访时结膜色素沉着较少相关[比值比,或0.09(95%置信区间,CI0.01;0.67)],而残留SRF的存在是术后1年随访时色素沉着的重要危险因素[OR5.89(95%CI1.84;23.12)].在2年的所有随访中,测得的色素沉着面积也与视网膜撕裂的数量呈正相关。6例患者在2年随访时出现结膜色素沉着。
    结论:带瓣套管的新型玻璃体切割技术可预防结膜色素沉着的术后出现。视网膜撕裂的数量,SRF的存在,长期使用填塞剂是最重要的诱发因素。玻璃体切除术后结膜色素沉着随时间逐渐减少。
    OBJECTIVE:  To investigate the incidence and the risk factors for conjunctival pigmentation at the sclerotomy sites following valved and non-valved cannula pars plana vitrectomy (PPV) performed by different surgical techniques.
    METHODS:  This is a prospective observational study which included 70 eyes of 70 patients who underwent PPV for rhegmatogenous retinal detachment with follow-up visits at 1, 3, 6, 12, and 24 months. Twenty-eight eyes were operated using 25G non-valved cannulas (Group A), 22 eyes using 25G non-valved cannulas (Group B), and 20 eyes using 25G valved cannulas (Group C). The evaluated clinical parameters include the surgical technique, the patients\' age, the number of retinal tears, the tamponade agent, the presence of residual sub-retinal fluid (SRF), and the duration of postoperative posturing.
    RESULTS:  Group A was associated with significant conjunctival pigmentation at up to 6 months after PPV. Sulfur hexafluoride (SF6) gas tamponade was associated with less conjunctival pigmentation at 3 months follow-up visit [odds ratio, OR 0.09 (95% confidence interval, CI 0.01; 0.67)], whereas the presence of residual SRF was a significant risk factor for postoperative pigmentation at 1-year follow-up visit [OR 5.89 (95% CI 1.84; 23.12)]. The area of measured pigmentation was also positively correlated to the number of retinal tears at all follow-up visits over 2 years. Six patients presented with conjunctival pigmentation at 2 years follow-up visit.
    CONCLUSIONS:  New vitrectomy techniques with valved cannulas prevent the postoperative appearance of conjunctival pigmentation. The number of retinal tears, the presence of SRF, and the use of long-standing tamponade agents were the most significant predisposing factors. The post-vitrectomy conjunctival pigmentation gradually reduces over time.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:报告非手术方法修复黄斑裂孔(MHs)的结果。方法:对2018年至2021年的连续MHs患者进行回顾性分析。局部治疗包括类固醇药物,一种非甾体药物,和碳酸酐酶抑制剂.收集的数据包括大小,舞台,和MH的持续时间;使用的局部药物和持续时间;晶状体状态;和并发症。黄斑水肿以0(无水肿)至4(大量水肿)的范围分级并记录。在MH关闭之前和之后,测量最佳矫正视力(BCVA)并转换为logMAR表示法。进行了频域光学相干层析成像。结果:最初局部治疗的13只眼睛中有7只(54%)经历了成功的MH闭合。具有更好的初始BCVA(0.474logMARvs0.796logMAR)的小孔(<230µm)更有可能对局部治疗产生有利反应(平均121µmvs499µm)。此外,周围水肿较少的孔反应更好。所有对局部治疗无反应的孔随后用平坦部玻璃体切除术封闭。膜剥离,和流体-气体交换。结论:局部治疗是MHs合理的一线治疗,成功率超过50%。对于具有最小或没有水肿的小的早发性孔尤其如此。在用滴眼液治疗MH时,延迟1至3个月后,手术成功率仍然很高。
    Purpose: To report the results of a nonsurgical approach to repair macular holes (MHs). Methods: A retrospective chart review of consecutive patients with MHs from 2018 to 2021 was performed. Topical therapy consisted of a steroidal agent, a nonsteroidal agent, and a carbonic anhydrase inhibitor. Data collected included the size, stage, and duration of the MH; topical agents used and the duration; lens status; and complications. Macular edema was graded on a scale ranging from 0 (no edema) to 4 (large amount of edema) and recorded. Before and after MH closure, the best-corrected visual acuity (BCVA) was measured and converted to logMAR notation. Spectral-domain optical coherence tomography was performed. Results: Seven (54%) of the 13 eyes initially treated topically experienced successful MH closure. Small holes (<230 µm) with a better initial BCVA (0.474 logMAR vs 0.796 logMAR) were more likely to respond favorably to topical therapy (mean 121 µm vs 499 µm). In addition, holes with less surrounding edema responded better. All holes not responding to topical therapy were subsequently closed with pars plana vitrectomy, membrane peeling, and fluid-gas exchange. Conclusions: Topical therapy is a reasonable first-line treatment for MHs, with a better than 50% success rate. This is especially true for small early-onset holes with minimal or no edema. Surgery still had a high success rate after a 1- to 3-month delay while the MH was treated with eyedrops.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:黄斑裂孔(MH)可严重损害中心视力。虽然可以用玻璃体切割手术治疗,避免复发和提高视力仍然是需要解决的优先事项。本研究旨在揭示MH的发展趋势和热点。
    方法:使用WebofScienceCoreCollection(WOSCC)进行了文献计量分析,调查了2002年至2021年MH研究的趋势。我们评估了相关区域的细节,机构,作者,和期刊。要构建和覆盖网络可视化,使用VOSviewer软件。
    结果:总计,收集了1518份出版物。我们的分析表明,MH研究变得越来越重要,日本的出版物数量最多(291),引用次数最多(共7745次),和最高h指数值(48)。Retina发表了关于这个主题的大多数出版物,总计超过接下来的两本期刊的总和。对关键词共现的分析进行了评估,突出几个有趣的新颖关键词,如皮瓣技术,移植,视网膜上增生(EP),中央凹微观结构,和视网膜敏感性。
    结论:通过全面分析过去二十年的全球趋势和热点,揭示了MH研究的细节,为未来的MH研究提供有价值的信息。Japan,美国,中国在这一主题的研究中处于领先地位。适当的手术方法是改善预后的潜在焦点。
    BACKGROUND: Macular hole (MH) can severely impair central vision. Although it can be treated with vitrectomy surgery, avoiding recurrence and improving visual acuity are still priorities to be addressed. This study aims to reveal the trends and hotspots about MH.
    METHODS: The Web of Science Core Collection (WOSCC) was used to perform a bibliometric analysis investigating trends of MH research from 2002 to 2021. We evaluated the details of associated regions, institutions, authors, and journals. To construct and overlay network visualizations, VOSviewer software was used.
    RESULTS: In total, 1518 publications were collected. Our analysis showed that MH research is becoming increasingly relevant, with Japan achieving the largest number of publications (291), largest number of citations (7745 in total), and highest h-index value (48). Retina published the most publications on this topic, totaling more than the next two journals combined. An analysis of keyword co-occurrence was evaluated, highlighting several novel keywords of interest, such as flap technique, transplantation, epiretinal proliferation (EP), foveal microstructure, and retinal sensitivity.
    CONCLUSIONS: Details on MH research were uncovered by comprehensively analyzing the global trends and hotspots over the past two decades, presenting valuable information for future MH research. Japan, the USA, and China hold leading positions in research on this topic. Amendable surgical methods are a potential focus for improving prognosis.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Case Reports
    lugdunensis葡萄球菌是玻璃体内注射后引起眼内炎的罕见病原体。它呈现出具有潜在破坏性结果的侵袭性疾病过程。在这种情况下,病人迟到时出现了严重的疼痛,双侧玻璃体内注射抗血管内皮生长因子后,视敏度从6/18降低至光知觉的红眼。严格遵守双侧玻璃体内注射方案意味着预防右眼感染。立即给予玻璃体内注射万古霉素,并进行紧急玻璃体活检,确认了S.lugdunensis为致病生物。由于这种生物的侵袭性,选择了强烈的口服和局部类固醇疗程。寻求早期玻璃体视网膜的意见,但由于最初改善了手部运动的视力,因此认为患者不适合进行玻璃体切除术。患者的视力改善至1/60,并且保持口服和局部类固醇的断奶状态,没有进一步的并发症。
    Staphylococcus lugdunensis is a rare causative organism of endophthalmitis following intravitreal injections. It presents an aggressive disease course with potentially devastating outcomes. In this case, the patient presented late with a severely painful, red eye with a reduced visual acuity from 6/18 to light perception following bilateral intravitreal injections of anti-vascular endothelial growth factor. Strict adherence to the bilateral intravitreal injection protocol meant prevention of infection in the right eye. Intravitreal vancomycin was administered without delay and an emergency vitreous biopsy was performed, confirming S. lugdunensis as the causative organism. An intense course of oral and topical steroids was chosen due to the aggressiveness of this organism. Early vitreo-retinal opinion was sought but the patient was deemed not suitable for vitrectomy due to initial improvements in visual acuity to hand movements. The patient showed improvements in the visual acuity to 1/60, and remains on a weaning regime of oral and topical steroids with no further complications.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    简介本研究旨在评估巴基斯坦流源性视网膜脱离(RRD)患者的25号平面玻璃体切除术(25gPPV)的主要解剖学成功和视觉效果。设计这是一个为期五年的回顾展,2013年10月至2018年10月在巴基斯坦三级医院进行的介入队列研究。方法这是一项回顾性研究,对418例接受25gPPV的RRD患者进行干预队列研究。所有手术均由巴基斯坦三级医院的两名经验丰富的外科医生进行。纳入2013年10月至2018年10月连续接受25gPPV手术治疗RRD的患者。我们排除了既往有视网膜手术史或未完成4-8周主要结局访视的患者。我们使用了社会科学统计软件包(SPSS)23.0版(IBM公司,Armonk,NY,美国)用于统计分析。<0.05的p值被认为是显著的。结果我们通过医院的编码系统确定了452例患者,在研究期间接受了25gPPV手术的RRD。该研究共审查了441份患者档案,其中418例患者符合最终分析标准。平均年龄为49±15.8岁。男性人数较多(n=284,占67.9%)。在我们的研究中,186例(44.4%)患者在就诊时出现了有晶状体。361例(86.4%)患者黄斑脱落。在主要结果访视(随访4-8周)时,主要解剖成功率为89.47%。最常见的失败原因是增生性玻璃体视网膜病变(PVR)(n=20),其次是错过的休息(n=5)。结论在我们的研究中,RRD与25gPPV手术的手术结果与发达国家报道的结果相似。我们提出了一项前瞻性多中心国家研究,以前瞻性评估巴基斯坦人群RRD手术失败的危险因素。
    Introduction This study aims to evaluate the primary anatomical success and visual outcomes of 25-gauge pars plana vitrectomy (25g PPV) in patients with rhegmatogenous retinal detachment (RRD) in Pakistan. Design This is a five-year retrospective, interventional cohort study conducted at tertiary care hospitals in Pakistan from October 2013 to October 2018. Methods This is a retrospective, interventional cohort study of 418 consecutive patients with RRD who underwent 25g PPV. All surgeries were performed by two experienced surgeons at tertiary care hospitals in Pakistan. Consecutive patients who underwent 25g PPV surgery as the treatment for RRD from October 2013 to October 2018 were included. We excluded patients who had a history of previous retinal surgery or did not complete the 4-8 weeks of primary outcome visit. We used the Statistical Package for the Social Sciences (SPSS) version 23.0 (IBM Corporation, Armonk, NY, USA) for statistical analysis. A p-value of <0.05 was considered significant. Results We identified 452 patients through the coding system of our hospitals who underwent 25g PPV surgery for RRD during the study period. A total of 441 patient files were reviewed for the study, of which 418 patients met the criteria for final analysis. The mean age was 49 ± 15.8 years. There was a higher number of males (n = 284, 67.9%). In our study, 186 (44.4%) patients were phakic at the time of presentation. The macula was detached in 361 (86.4%) patients. At the primary outcome visit (4-8 weeks of follow-up), the primary anatomical success rate was 89.47%. The most common cause of failure was proliferative vitreoretinopathy (PVR) (n = 20), followed by missed breaks (n = 5). Conclusions The surgical outcomes of RRD with 25g PPV surgery in our study were similar to the outcomes reported in the developed world. We propose a prospective multicenter national study to prospectively evaluate the risk factors for RRD surgical failure in the Pakistani population.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    玻璃体视网膜手术需要在选定的患者组中进行全身麻醉(GA)。GA期间术中抢救麻醉镇痛(IRNA)的给药存在术后恶心和呕吐(PONV)的风险。手术面积指数(SPI),GA麻醉(AoA)指导充分性的关键组成部分,优化IRNA的术中滴定。目前的分析评估了在AoA指导下接受平坦部玻璃体切除术(PPV)的患者发生PONV和眼心反射(OCR)的危险因素。总的来说,175名接受PPV的患者被随机分配接受GA和SPI指导的IRNA给药,使用芬太尼单独或除了不同的术前镇痛技术。记录PONV或OCR的任何发生率。肥胖,超重,吸烟状况,晕车,术后难以忍受的疼痛感知,女性性别,在AoA指导下,液体激发和动脉高血压与PONV或OCR的发生率增加无关.糖尿病,不管胰岛素依赖,被发现与PONV的发病率增加有关。包括IRNA的SPI指导的AoA方案可能为个体受试者创造了相似的条件,所以没有发现PONV或OCR发生的危险因素,除了糖尿病。我们建议使用AoA指导GA给药,以降低OCR和PONV率。
    Vitreoretinal surgeries require the administration of general anesthesia (GA) in selected groups of patients. The administration of intraoperative rescue narcotic analgesia (IRNA) during GA poses the risk of postoperative nausea and vomiting (PONV). The surgical pleth index (SPI), a crucial component of the adequacy of anesthesia (AoA) guidance of GA, optimizes the intraoperative titration of IRNA. The current analysis evaluated the risk factors for the occurrence of PONV and the oculo-cardiac reflex (OCR) in patients undergoing pars plana vitrectomy (PPV) under AoA guidance. In total, 175 patients undergoing PPV were randomly allocated to receive either GA with SPI-guided IRNA administration using fentanyl alone or in addition to different preoperative analgesia techniques. Any incidence of PONV or OCR was recorded. Obesity, overweight, smoking status, motion sickness, postoperative intolerable pain perception, female gender, fluid challenge and arterial hypertension did not correlate with an increased incidence of PONV or OCR under AoA guidance. Diabetes mellitus, regardless of insulin dependence, was found to correlate with the increased incidence of PONV. The AoA regimen including SPI guidance of IRNA presumably created similar conditions for individual subjects, so no risk factors of the occurrence of PONV or OCR were found, except for diabetes mellitus. We recommend using AoA guidance for GA administration to reduce OCR and PONV rates.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Case Reports
     Retinal detachment in congenital glaucoma is rare and often associated with a poor prognosis. In this report, we describe ocular manifestations of congenital glaucoma, pre- and post-operative ophthalmic findings, and overall anatomic and functional outcomes after successful rhegmatogenous retinal detachment repair along with a review of the literature. Rhegmatogenous retinal detachment in a 45-year-old monocular patient with congenital glaucoma was successfully repaired with small gauge pars plana vitrectomy, intra-operative perfluorocarbon use and 1,000 centistoke silicone oil tamponade. Best-corrected visual acuity improved from CF to 20/70; however, the post-operative course was complicated by hypotony-associated maculopathy after removal of silicone oil. Five thousand centistoke silicone oil was reinfused with good anatomic and functional outcomes. The functional outcome may ultimately be limited by pre-existing amblyopia and other ocular comorbidities.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号